HuagongsheHuagongshe Chemistry Print Report · For research reference only
Isbogrel
CV-4151 · ISBOGREL · ISBOGREL USP/EP/BP · (E)-7-Phenyl-7-(3-pyridinyl)-6-heptenoic acid · (E)-7-Phenyl-7-(pyridin-3-yl)hept-6-enoic acid · 6-Heptenoic acid, 7-phenyl-7-(3-pyridinyl)-, (6E)-

Identifiers & Physical Properties
| CAS No. | 89667-40-3 |
|---|---|
| Molecular formula | C18H19NO2 |
| Average molar mass | 281.3 g/mol |
| Monoisotopic mass | 281.14157885 g/mol |
| SMILES | O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 |
| InChIKey | UWPBQLKEHGGKKD-GZTJUZNOSA-N |
| PubChem CID | 5284442 |
| ChEMBL | CHEMBL26820 |
| EC No. | 887-203-5 |
| DTXSID | DTXSID4021133 |
Chemical & Physical Properties
| XLogP | 4 |
|---|---|
| Topological polar surface area | 50.2 |
| Hydrogen bond donors | 1 |
| Hydrogen bond acceptors | 3 |
| Rotatable bonds | 7 |
| Heavy atoms | 21 |
| Formal charge | 0 |
| Complexity | 345 |
| Melting point | 114-115° |
| Storage conditions | 2-8°C |
| FDA UNII | HGB7P08R36 |
| GHS pictogram | GHS07 |
| Signal word | Warning |
| GHS hazard statements | H315-H319 |
| GHS precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
Safety & Regulations
| GHS classification | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| Signal word | Warning |
| GHS pictogram | GHS07 |
| GHS hazard statements | H315-H319 |
| GHS precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
Applications & Uses
Uses
Isbogrel is used as Thromboxane A2 inhibitor and for the treatment of short-term myocardial ischemia.